For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Aclaris Therapeutics Inc’s stock clocked out at $2.45, down -2.39% from its previous closing price of $2.51. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.51 million shares were traded. ACRS stock price reached its highest trading level at $2.5395 during the session, while it also had its lowest trading level at $2.39.
Ratios:
To gain a deeper understanding of ACRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.03 and its Current Ratio is at 7.03. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Leerink Partners Upgraded its Market Perform to Outperform on November 19, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRS now has a Market Capitalization of 262196560 and an Enterprise Value of 53814664. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.68 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 1.987 whereas that against EBITDA is -0.865.
Stock Price History:
The Beta on a monthly basis for ACRS is 0.51, which has changed by 1.0743802 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -19.93%, while the 200-Day Moving Average is calculated to be 42.63%.
Shares Statistics:
It appears that ACRS traded 2.67M shares on average per day over the past three months and 1078320 shares per day over the past ten days. A total of 107.02M shares are outstanding, with a floating share count of 95.31M. Insiders hold about 10.94% of the company’s shares, while institutions hold 48.86% stake in the company. Shares short for ACRS as of 1735603200 were 3562311 with a Short Ratio of 1.34, compared to 1732838400 on 2480701. Therefore, it implies a Short% of Shares Outstanding of 3562311 and a Short% of Float of 3.73.
